Abemaciclib - Wikipedia
Abemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6 .
Abemaciclib: Uses, Dosage, Side Effects, Warnings - Drugs.com
Oct 6, 2024 · Abemaciclib (brand name Verzenio) may be used to treat adults with HR-positive, HER2-negative, node-positive early breast cancer that has a high risk of returning or HR+, HER2- breast cancer that has spread (metastasized).
Abemaciclib (oral route) - Mayo Clinic
Description. Abemaciclib is used together with tamoxifen or an aromatase inhibitor (eg, anastrozole, exemestane, letrozole) to treat hormone receptor (HR)-positive, HER-2 negative, node-positive, early breast cancer with a high risk of coming back as determined by your doctor.
Abemaciclib: MedlinePlus Drug Information
Abemaciclib is used in combination with tamoxifen (Soltamox) or an aromatase inhibitor such as anastrozole (Arimidex), exemestane (Aromasin), or letrozole (Femara) to treat a certain type of hormone receptor-positive, early breast cancer.
Abemaciclib (Verzenios) - Breast Cancer Now
When used to treat breast cancer, abemaciclib is taken alongside hormone (endocrine) therapy. Abemaciclib is the drug’s non-branded name. Its brand name is Verzenios. It belongs to a group of drugs called CDK (cyclin dependent kinase) inhibitors.
Abemaciclib - NCI - National Cancer Institute
This page contains brief information about abemaciclib (Verzenio) and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Verzenio (Abemaciclib): What to Expect, Side Effects, and ...
Verzenio treats all stages of hormone-receptor-positive, HER2-negative breast cancer by stopping cancer cells from dividing and growing.
HR+, HER2- Early and Metastatic Breast Cancer Treatment ...
Verzenio (abemaciclib) is a treatment for both HR+, HER2-, high risk, node positive early breast cancer and for certain types of HR+, HER2- metastatic breast cancer.
Verzenio (abemaciclib) - Uses, Side Effects, and More - WebMD
Jul 13, 2024 · Verzenio (abemaciclib) is commonly used for treating breast cancer that is hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative. It treats early breast...
Abemaciclib (Verzenois) - Cancer Research UK
Apr 8, 2024 · Abemaciclib is a type of targeted cancer drug. You pronounce it as a-bee-ma-sye-klib. It is also known as Verzenios. It is a treatment for breast cancer that has: spread to another part of the body (secondary or metastatic breast cancer)